"I think the concern you have as a lender...is that this is a company not meeting its plan and not hitting covenants and it may be delaying the inevitable."--Eric Goodison, partner at Paul, Weiss, Rifkind, Wharton & Garrison, on why lenders may not like equity cure rights written into commitment letters.